CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Prakt. Lék., 2007, 87, No. 10, pp. 618-623
 
Initial experience using a laser-balloon endoscopic catheterfor the tre-atment ofpatients with paroxysmal atrial fibrillation 
ŠKODA J.i, NEUŽIL P.1, REDDY V.Y.2, PETRŮ J.1, ŠEDIVÁ L.1, TÁBORSKÝ M.1, RAVIELE A.3, ERNST S.4, KUCK K.H.4, NATALE A.5  

1Kardiologické oddělení Nemocnice Na Homolce, Praha
 


Summary:

       Background: During catheter ablation of atrial fibrillation (AF), placing contiguous point ablation lesions to electrically-isolate the pulmonary veins (PV) can be technically challenging. A novel balloon catheter (Endoscopic Ablation System - EAS; Cardiofocus, Inc.) which utilizes a miniatuře endoscope for real-time visualization during ablation has been developed. This systém employs arcs of light-energy that are adjustable (rotating, advancing, retracting) independent of the balloon to direct energy to the pulmonary veins PV-left atrium(LA) region. This report details the first clinical long-term follow-up results from a prospective multcentric trial in patients from our center. Methods: 22 patients with a history of symptomatic drug-resistant paroxysmal AF were studied: Sex: M/F = 19/3; Age 53 ± 8 years (29-73); AF duration: 7.0 ± 3.0 years (1-14); LA diameter: 42 ± 4 mm (33-49); left ventricular ejection fraction (LVEF) 68 ± 4% (45-77). A single treatment consisting of isolation of the PV ostia was delivered using the EAS. There were no exclusion criteria related to morphology/number of PVs Results: During long-term follow-up 17.1 ± 6.6 months (7-27) AF free endpoint was achieved in 19 (86.3%) patients, of whom 7 (33 %) patients needed adjunctive betablocker and/or propafenon. Three patients (13.6 %) experienced AF despite antiarrhythmic therapy, the proceduře was successfully repeated in one patient. During 6 to 12 moths follow-up visits, a computed tomography revealed only mild stenosis 26.4 ± 4,4 % (20-37) in 16 % of PVs. Two adverse events were documented: transient ischemic attack, and pseudoaneurysm of a right femoral artery solved by a percutaneous glue-tissue application. The time of proceduře + fluoroscopy significantly decreased during a learning curve. Conclusion: This initial clinical-feasibility study suggests that a single treatment with the EAS of paroxysmal AF appears safe and efficacious. Key

        Key words: paroxysmal atrial fibrillation, catheter ablation, transseptal puncture, pulmonary vein isolation, light-energy laser are.
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER